Wendy Kan
Lawyers
Filters
Xunce concurrent HK$784M placement of new H shares and CNY1.36B convertible bonds
We advised Xunce on its concurrent placement of new H shares and convertible bonds issuance
Alebund Pharmaceuticals HK$1.28 billion IPO
We advised Alebund Pharmaceuticals on its IPO and HKEX listing
METiS TechBio HK$2.43 billion IPO
We advised METiS TechBio on its IPO and HKEX listing
Mabwell Bioscience HK$1.2 billion IPO
We advised Mabwell on its IPO and HKEX listing
MiniMax Group HK$4.8 billion IPO
We advised MiniMax Group on its IPO and HKEX listing
Shenzhen Xunce Technology HK$1.08 billion IPO
We advised Xunce on its IPO and HKEX listing
PegBio HK$300 million placement of shares
We advised PegBio on the placement of new shares
Ascletis HK$861.98 million placement of shares and top-up subscription
We advised the placing agent on the placement and the top-up subscription
Medtide HK$411.2 million IPO
We advised Medtide on its IPO and HKEX listing
Mirxes Holding Company HK$1.09 billion IPO
We advised Mirxes on its IPO and HKEX listing